{"transactions":[{"id":681677,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2026-08-19T23:00:13.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 4,000 shares of common stock (the \"Options\") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 4,000 shares of common stock (the \"Options\") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include the stock options previously granted to the Reporting Person."}],"balance_after":4000,"derivative":{"exercise_price":1.36,"expiration_date":"2036-08-17","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001493152-26-039290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315226039290/ownership.xml","form_type":"4"}},{"id":1056934,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-08-26T00:47:37.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant."}],"balance_after":125000,"derivative":{"exercise_price":2,"exercise_date":"2025-08-21","expiration_date":"2030-08-21","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001641172-25-025446","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000164117225025446/ownership.xml","form_type":"4"}},{"id":1056933,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-26T00:47:37.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":125000,"price":2,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant."}],"balance_after":130650,"source":{"system":"sec-edgar","filing":"0001641172-25-025446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000164117225025446/ownership.xml","form_type":"4"}},{"id":1087431,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2025-07-16T00:42:54.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":137078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 15, 2025, the Reporting Person was issued a non-qualified stock option to purchase 137,078 shares of common stock (the \"Options\") at an exercise price of $0.70 per share (equal to the closing price on the grant date, July 9, 2025) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 15, 2025, the Reporting Person was issued a non-qualified stock option to purchase 137,078 shares of common stock (the \"Options\") at an exercise price of $0.70 per share (equal to the closing price on the grant date, July 9, 2025) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."}],"balance_after":137078,"derivative":{"exercise_price":0.7,"expiration_date":"2035-07-09","underlying":"Common Stock","underlying_shares":137078},"source":{"system":"sec-edgar","filing":"0001641172-25-019800","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000164117225019800/ownership.xml","form_type":"4"}},{"id":1315481,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T22:25:58.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":11684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") on December 31, 2024 (the \"Grant Date\"), pursuant to the Issuer's 2023 Equity Incentive Plan and subject to the conditions of a Restricted Stock Unit Award Agreement, in a transaction exempt under Rule 16b-3 to the Reporting Person, who is a non-employee director with the Issuer, in connection with a payment in lieu of cash for services during the Issuer's fourth fiscal quarter. Each RSU represents a contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The RSUs fully vested on the Grant Date. The price per share at which the grants were issued is $1.15 and was determined based on the Issuer's closing price on December 31, 2024."}],"balance_after":67774,"source":{"system":"sec-edgar","filing":"0001493152-25-000302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315225000302/ownership.xml","form_type":"4"}},{"id":1386788,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2024-10-16T01:14:37.000Z","date":"2024-09-20","kind":"grant","planned":false,"acquired":true,"shares":20217,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."}],"balance_after":20217,"derivative":{"exercise_price":1.09,"expiration_date":"2034-09-20","underlying":"Common stock","underlying_shares":20217},"source":{"system":"sec-edgar","filing":"0001493152-24-041199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315224041199/ownership.xml","form_type":"4"}},{"id":1463516,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T00:22:46.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":67187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") on June 28, 2024 (the \"Grant Date\"), pursuant to the Issuer's 2023 Equity Incentive Plan and subject to the conditions of a Restricted Stock Unit Award Agreement, in a transaction exempt under Rule 16b-3 to the Reporting Person, who is a non-employee director with the Issuer, in connection with services for the Issuer's second fiscal quarter. Each RSU represents a contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The RSUs fully vested on the Grant Date."}],"balance_after":560873,"source":{"system":"sec-edgar","filing":"0001493152-24-026117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315224026117/ownership.xml","form_type":"4"}},{"id":1463515,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T00:16:42.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":23783,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") on March 29, 2024 (the \"Grant Date\"), pursuant to the Issuer's 2023 Equity Incentive Plan and subject to the conditions of a Restricted Stock Unit Award Agreement, in a transaction exempt under Rule 16b-3 to the Reporting Person, who is a non-employee director with the Issuer, in connection with services for the Issuer's first fiscal quarter. Each RSU represents a contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The RSUs fully vested on the Grant Date."}],"balance_after":493686,"source":{"system":"sec-edgar","filing":"0001493152-24-026111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315224026111/ownership.xml","form_type":"4"}},{"id":1688442,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2024-01-05T00:49:56.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":70249,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on December 21, 2023 (the \"Grant Date\"), the Reporting Person was granted 70,249 Non-Qualified Stock Options (the \"Options\") at an exercise price of $1.80, which is equal to the closing price of the Issuer's common stock on December 21, 2023, for serving as a director. Options will vest in one year or at the next annual shareholder meeting, whichever occurs first. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on December 21, 2023 (the \"Grant Date\"), the Reporting Person was granted 70,249 Non-Qualified Stock Options (the \"Options\") at an exercise price of $1.80, which is equal to the closing price of the Issuer's common stock on December 21, 2023, for serving as a director. Options will vest in one year or at the next annual shareholder meeting, whichever occurs first. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person."}],"balance_after":70249,"derivative":{"exercise_price":1.8,"expiration_date":"2033-12-21","underlying":"Common stock","underlying_shares":70249},"source":{"system":"sec-edgar","filing":"0001493152-24-001132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315224001132/ownership.xml","form_type":"4"}},{"id":1688441,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21706,"kind":"person","name":"Leftwich Scott","position":1,"cik":"0001991668","reported_name":"Leftwich Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-05T00:49:56.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":8958,"price":1.8,"value":16124.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of restricted stock units (\"RSUs\") subject to the conditions of the Restricted Stock Unit Award Agreement pursuant to the Issuer's 2023 Plan. Each RSU represents a right to receive one share of the Company's common stock upon vesting. The number of RSUs to be issued will equal to the amount due to the director for Board fees divided by the closing price for a share of the Issuer's common stock of $1.80. The RSUs were granted in a transaction exempt under Rule 16b-3 to the Reporting Person. The shares of common stock underlying the RSUs immediately vested on the Grant Date."}],"balance_after":469903,"source":{"system":"sec-edgar","filing":"0001493152-24-001132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991668/000149315224001132/ownership.xml","form_type":"4"}}]}